Roche Holding AG - Minority Interest Expense
Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Minority-Interest-Expense" stands at -0.224 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 06/30/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.14 Billion Swiss Francs compared to the value the year prior.
The 1 year change is -1.14 Billion Swiss Francs.
The 3 year change is -1.47 Billion Swiss Francs.
The 5 year change is 12.63 Billion Swiss Francs.
The 10 year change is -0.513 Billion Swiss Francs.
The Serie's change in Swiss Francs from it's minimum value, on 06/30/2021, to it's latest available value, on 06/30/2025, is +13.88 Billion.
The Serie's change in Swiss Francs from it's maximum value, on 03/31/2023, to it's latest available value, on 06/30/2025, is -1.83 Billion.
Minority Interest Expense for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Minority Interest Expense | 905,699,262,464.00 |
 | Johnson & Johnson - Minority Interest Expense | 486,508,953,600.00 |
 | AbbVie Inc - Minority Interest Expense | 399,570,305,024.00 |
 | AstraZeneca PLC - Minority Interest Expense | 280,205,508,085.11 |
 | Novartis AG - Minority Interest Expense | 255,096,620,580.91 |